These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10799910)

  • 21. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
    Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
    J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.
    Taylor FB; Stearns-Kurosawa DJ; Kurosawa S; Ferrell G; Chang AC; Laszik Z; Kosanke S; Peer G; Esmon CT
    Blood; 2000 Mar; 95(5):1680-6. PubMed ID: 10688824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats.
    Cui X; Zeni F; Vodovitz Y; Correa-de-Araujo R; Quezado M; Roberts A; Wahl S; Danner RL; Banks SM; Gerstenberger E; Fitz Y; Natanson C; Eichacker PQ
    Cytokine; 2003 Nov; 24(4):115-27. PubMed ID: 14572790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis.
    Chang YS; Kang S; Ko SY; Park WS
    J Korean Med Sci; 2006 Dec; 21(6):965-72. PubMed ID: 17179670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia.
    Zeni F; Parent C; Correa R; Natanson C; Freeman B; Fontana J; Quezado M; Danner RL; Fitz Y; Richmond S; Gerstenberger E; Banks SM; Eichacker PQ
    J Appl Physiol (1985); 1999 Jul; 87(1):299-307. PubMed ID: 10409588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood.
    Christiansen D; Brekke OL; Stenvik J; Lambris JD; Espevik T; Mollnes TE
    Adv Exp Med Biol; 2012; 946():237-51. PubMed ID: 21948372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The innate immune response to lower respiratory tract E. Coli infection and the role of the CCL2-CCR2 axis in neonatal mice.
    McGrath-Morrow SA; Ndeh R; Collaco JM; Poupore AK; Dikeman D; Zhong Q; Singer BD; D'Alessio F; Scott A
    Cytokine; 2017 Sep; 97():108-116. PubMed ID: 28628889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice.
    Gao X; Xu N; Sekosan M; Mehta D; Ma SY; Rahman A; Malik AB
    J Immunol; 2001 Sep; 167(5):2895-901. PubMed ID: 11509637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.
    Dallaire F; Ouellet N; Bergeron Y; Turmel V; Gauthier MC; Simard M; Bergeron MG
    J Infect Dis; 2001 Aug; 184(3):292-300. PubMed ID: 11443554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Hepatic STAT3 Maintains Pulmonary Defense during Endotoxemia.
    Hilliard KL; Allen E; Traber KE; Kim Y; Wasserman GA; Jones MR; Mizgerd JP; Quinton LJ
    Infect Immun; 2015 Oct; 83(10):4015-27. PubMed ID: 26216424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.
    Wölbeling F; Munder A; Kerber-Momot T; Neumann D; Hennig C; Hansen G; Tümmler B; Baumann U
    Immunobiology; 2011 Aug; 216(8):901-8. PubMed ID: 21497410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis.
    Mohr M; Höpken U; Oppermann M; Mathes C; Goldmann K; Siever S; Götze O; Burchardi H
    Eur J Clin Invest; 1998 Mar; 28(3):227-34. PubMed ID: 9568469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.
    Degousee N; Kelvin DJ; Geisslinger G; Hwang DM; Stefanski E; Wang XH; Danesh A; Angioni C; Schmidt H; Lindsay TF; Gelb MH; Bollinger J; Payré C; Lambeau G; Arm JP; Keating A; Rubin BB
    J Biol Chem; 2011 Oct; 286(41):35650-35662. PubMed ID: 21849511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.
    Martin TR; Mathison JC; Tobias PS; Letúrcq DJ; Moriarty AM; Maunder RJ; Ulevitch RJ
    J Clin Invest; 1992 Dec; 90(6):2209-19. PubMed ID: 1281827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice.
    Huber-Lang M; Barratt-Due A; Pischke SE; Sandanger Ø; Nilsson PH; Nunn MA; Denk S; Gaus W; Espevik T; Mollnes TE
    J Immunol; 2014 Jun; 192(11):5324-31. PubMed ID: 24790148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae.
    Dessing MC; Knapp S; Florquin S; de Vos AF; van der Poll T
    Am J Respir Crit Care Med; 2007 Mar; 175(6):604-11. PubMed ID: 17185649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia.
    Su X; Johansen M; Looney MR; Brown EJ; Matthay MA
    J Immunol; 2008 May; 180(10):6947-53. PubMed ID: 18453616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression of Toll-like receptor-2, Toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia.
    Kajikawa O; Frevert CW; Lin SM; Goodman RB; Mongovin SM; Wong V; Ballman K; Daubeuf B; Elson G; Martin TR
    Gene; 2005 Jan; 344():193-202. PubMed ID: 15656985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14).
    Reinhart K; Glück T; Ligtenberg J; Tschaikowsky K; Bruining A; Bakker J; Opal S; Moldawer LL; Axtelle T; Turner T; Souza S; Pribble J
    Crit Care Med; 2004 May; 32(5):1100-8. PubMed ID: 15190957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.